These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2543146)
1. Differential diagnosis between secondary hyperparathyroidism and aluminum intoxication in uremic patients: usefulness of 99mTc-pyrophosphate bone scintigraphy. Kinnaert P; Van Hooff I; Schoutens A; Bergmann P; Fuss M; Dratwa M; Vienne A; Pasteels JL; van Geertruyden J; Vanherweghem JL World J Surg; 1989; 13(2):219-23; discussion 223-4. PubMed ID: 2543146 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia. Vanherweghem JL; Dhaene M; Tielemans C; Dratwa M; Verbanck P; Bergmann P; Schoutens A; Fuss M Proc Eur Dial Transplant Assoc; 1981; 18():648-51. PubMed ID: 6276883 [TBL] [Abstract][Full Text] [Related]
3. Effects of renal failure and metabolic diseases upon bone scanning in children. Schümichen C Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830 [No Abstract] [Full Text] [Related]
4. Common bone features in osteomalacia, secondary hyperparathyroidism, and renal osteodystrophy. Verlooy H; De Roo M; Mortelmans L; Dequeker J Clin Nucl Med; 1991 May; 16(5):372-4. PubMed ID: 2054996 [No Abstract] [Full Text] [Related]
5. Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease. Rosenthall L; Kaye M J Nucl Med; 1975 Jan; 16(1):33-9. PubMed ID: 162946 [TBL] [Abstract][Full Text] [Related]
6. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques. Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343 [TBL] [Abstract][Full Text] [Related]
7. Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy. Karsenty G; Vigneron N; Jorgetti V; Fauchet M; Zingraff J; Drüeke T; Cournot-Witmer G Kidney Int; 1986 May; 29(5):1058-65. PubMed ID: 3723927 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of 99mTc pyrophosphate bone scintigraphy in the survey of dialysis osteodystrophy. Vanherweghem JL; Schoutens A; Bergman P; Dhaene M; Goldman M; Fuss M; Kinnaert P Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():431-4. PubMed ID: 2986102 [TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
10. Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining. Hodsman AB; Steer BM J Am Soc Nephrol; 1992 Feb; 2(8):1318-27. PubMed ID: 1378308 [TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of osteomalacia and other forms of renal osteodystrophy in terminal renal failure by dynamic scintigraphy with diphosphonate]. Novikov AI; Ermolenko AE; Ermakova IP; Baeva LB; Levitskiĭ ER Ter Arkh; 1989; 61(6):105-9. PubMed ID: 2799693 [TBL] [Abstract][Full Text] [Related]
13. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis]. Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177 [TBL] [Abstract][Full Text] [Related]
14. Management of bone disease in the dialysis patient. Crooks PW; Coburn JW Blood Purif; 1985; 3(1-3):27-41. PubMed ID: 3913448 [TBL] [Abstract][Full Text] [Related]
15. [Classification of bone scintigrams in hemodialysis patients]. Ishibashi K; Miyamae T Kaku Igaku; 1985 Mar; 22(3):367-76. PubMed ID: 3160875 [No Abstract] [Full Text] [Related]
16. Renal osteodystrophy: some new questions on an old disorder. Lee DB; Goodman WG; Coburn JW Am J Kidney Dis; 1988 May; 11(5):365-76. PubMed ID: 3285668 [TBL] [Abstract][Full Text] [Related]
17. [Renal osteodystrophy (3); its treatment in dialysis patients]. Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385 [TBL] [Abstract][Full Text] [Related]
18. [Value of bone scintigraphy in secondary (intestinal) hyperparathyroidism]. Braun W; Heidenreich P; Guth H Rofo; 1984 Apr; 140(4):457-63. PubMed ID: 6232181 [TBL] [Abstract][Full Text] [Related]
19. Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidism. Kida T; Hujita Y; Sasaki M; Inoue J Eur J Nucl Med; 1986; 12(3):151-4. PubMed ID: 3758104 [TBL] [Abstract][Full Text] [Related]
20. [Metastatic calcifications as demonstrated by technetium-99m-pyrophosphate bone scanning. Case reports]. Louw NW; Klopper JF; van Heerden PD S Afr Med J; 1982 Oct; 62(17):617-20. PubMed ID: 6289479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]